Eli Lilly News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

11.06.18	Elanco Animal Health Introduces New Respiratory PRRS Vaccine (PR Newswire)
11.06.18	Eli Lilly To Present New Data From Its Immunology Portfolio - Quick Facts (RTTNews)
11.06.18	Lilly to Unveil New Data at the Annual European Congress of Rheumatology, Furthering Commitment to Scientific Discovery in Immunology (PR Newswire)
05.06.18	Lilly Recommends Shareholders Reject Below-Market Mini-Tender Offer by TRC Capital Corp. (PR Newswire)
05.06.18	DDW 2018: Patients with Moderate-to-Severe Ulcerative Colitis Achieved Clinical and Endoscopic Remission with Mirikizumab in Phase 2 Trial (PR Newswire)
05.06.18	Eli Lilly: FDA Expands ALIMTA Label To Include Combination With KEYTRUD (RTTNews)
05.06.18	FDA Expands Lilly's ALIMTA® (pemetrexed) Label to Include Combination with KEYTRUDA® (pembrolizumab) and Carboplatin as First-Line Treatment for Metastatic Nonsquamous Non-Small Cell Lung Cancer,... (PR Newswire)
04.06.18	FDA Nod For LLY/INCY RA Drug, JAZZ Hits Right Tones, SLS' Study Stopped Early (RTTNews)
01.06.18	FDA Approves OLUMIANT® (baricitinib) 2-mg Tablets for the Treatment of Adults with Moderately-to-Severely Active Rheumatoid Arthritis (PR Newswire)
01.06.18	Lilly to Showcase New Data at Digestive Disease Week 2018 for Mirikizumab in Moderate-to-Severe Ulcerative Colitis (PR Newswire)
31.05.18	Lilly to Participate in Goldman Sachs Global Healthcare Conference (PR Newswire)
30.05.18	Lilly to Participate in Jefferies Global Healthcare Conference (PR Newswire)
23.05.18	Sue Mahony to Retire as President of Lilly Oncology (PR Newswire)
23.05.18	Elanco, Heifer International 10-Year Effort Breaks the Cycle of Hunger for 160,000 Families (PR Newswire)
22.05.18	Eli Lilly: FDA Approves Label Update For Taltz - Quick Facts (RTTNews)
22.05.18	Lilly's Taltz® (ixekizumab) Receives the First U.S. FDA Approval for Label Update to Include Data for Psoriasis Involving the Genital Area (PR Newswire)
18.05.18	AAM to Present at the 2018 Barclays High Yield Bond and Syndicated Loan Conference on May 22 (PR Newswire)
16.05.18	Lilly Data at ASCO Illustrate Patient-Driven Advances in Cancer Care (PR Newswire)
16.05.18	LLY Gets Headache Relief, XENE Abuzz, 3rd Time's A Charm For PFE's Epogen Biosim (RTTNews)
15.05.18	Eli Lilly: Galcanezumab Meets Primary Endpoint In Phase 3 Study - Quick Facts (RTTNews)
15.05.18	Lilly's Galcanezumab Meets Primary Endpoint in Phase 3 Study Evaluating Galcanezumab for the Prevention of Episodic Cluster Headache (PR Newswire)
14.05.18	WeissLaw LLP: ARMO BioSciences Inc. Acquisition May Not Be In The Best Interests of ARMO shareholders (PR Newswire)
14.05.18	Lilly To Buy AurKa Pharma (RTTNews)
14.05.18	Lilly to Acquire AurKa Pharma (PR Newswire)
12.05.18	An Ear To The Pharma: 8 Stocks To Watch (VYGR, BOLD, RXII, CYAD…) (RTTNews)
11.05.18	Lilly to Participate in UBS Global Healthcare Conference (PR Newswire)
10.05.18	Eli Lilly To Acquire ARMO BioSciences For Approx. $1.6 Bln - Quick Facts (RTTNews)
10.05.18	Elanco Animal Health Announces Addition of General Counsel (PR Newswire)
10.05.18	Lilly Announces Agreement To Acquire ARMO BioSciences (PR Newswire)
07.05.18	Lilly Declares Second-Quarter 2018 Dividend (PR Newswire)
01.05.18	Lilly and Local Partners Launch Diabetes Prevention and Management Pilot in Three Underserved Neighborhoods in Indianapolis (PR Newswire)
30.04.18	Leena Gandhi, M.D., Ph.D., to Lead Lilly Oncology Immuno-Oncology Medical Development (PR Newswire)
27.04.18	Lilly to Participate in Bank of America Merrill Lynch Health Care Conference (PR Newswire)
25.04.18	Lilly and China's NCCD announce collaboration to advance scientific understanding and care for people living with diabetes and cardiovascular disease (PR Newswire)
24.04.18	Lilly Q1 Results Beat Estimates; Raises 2018 Outlook (RTTNews)
24.04.18	Eli Lilly And Co. Q1 adjusted earnings Beat Estimates (RTTNews)
24.04.18	Lilly Reports Strong First-Quarter 2018 Results, Raises EPS Guidance (PR Newswire)
24.04.18	AAN 2018: Lilly's Galcanezumab Significantly Reduced Monthly Migraine Headache Days in Patients with Migraine Who Previously Failed to Respond to Multiple Preventive Therapies (PR Newswire)
24.04.18	PRTA Jolted, FDA Strikes Down PFE's Herceptin Biosimilar, No Relief Yet For KMDA (RTTNews)
24.04.18	FDA Panel Backs Lower Dose Of Lilly-Incyte Arthritis Drug, But Not Higher Dose (RTTNews)
24.04.18	FDA Advisory Committee Recommends the Approval of Baricitinib 2mg, but not 4mg, for the Treatment of Moderately-to-Severely Active Rheumatoid Arthritis (PR Newswire)
23.04.18	Elanco Announces Addition of Chief Financial Officer (PR Newswire)
21.04.18	An Ear To The Pharma: 10 Stocks To Watch (BHVN, LLY, TOCA, ALDR…) (RTTNews)
20.04.18	Lilly Reports Additional Top-Line Results from CYRAMZA® (ramucirumab) Phase 3 RANGE Study in Advanced or Metastatic Urothelial Cancer (PR Newswire)
20.04.18	Lilly to Present Phase 3 Data at AAN 2018 Reinforcing Commitment to New, Innovative Therapies in Migraine (PR Newswire)
16.04.18	Boehringer Ingelheim and Lilly announce an academic collaboration with University of Oxford to investigate the effects of Jardiance® in adults with chronic kidney disease (PR Newswire)
15.04.18	St. Baldrick's Foundation Commits $8 million to Support Pediatric Cancer Dream Team with Stand Up To Cancer (PR Newswire)
05.04.18	CNAT Disappoints, EBIO To Report VISTA Data In May, PRTK To Face FDA In Oct. (RTTNews)
04.04.18	Lilly Confirms Date and Conference Call for First-Quarter 2018 Financial Results Announcement (PR Newswire)
04.04.18	Eli Lilly, Sigilon Announce Global Collaboration - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Logitech Intl	71.14	1.54 %	K V
UBS Group	28.08	1.48 %	K V
Swiss Re	130.05	1.05 %	K V
Part Grp Hldg	1’266.00	0.96 %	K V
ABB	49.48	0.94 %	K V
Geberit	525.20	0.27 %	K V
Alcon	78.04	0.05 %	K V
Givaudan	3’868.00	-0.31 %	K V
CieFinRichemont	121.20	-0.57 %	K V
Sonova Hldg	301.00	-0.99 %	K V

mehr

19:12		TELL me! - der Schweizer Trading Podcast: Microsoft unter Kartellverdacht - Novartis auf einem guten Weg - bei Brenntag könnte das zyklische Tief 2025 kommen
17:58		Optimismus in Europa: Euro STOXX 50 zum Ende des Donnerstagshandels in der Gewinnzone
17:58		Freundlicher Handel in Frankfurt: LUS-DAX verbucht schlussendlich Gewinne
17:58		DAX aktuell: DAX zum Handelsende mit Zuschlägen
15:58		Börse Europa: STOXX 50-Börsianer greifen zu
12:26		Gewinne in Europa: STOXX 50 am Mittag mit Kursplus
09:28		Freundlicher Handel in Europa: Euro STOXX 50 zum Start fester
09:28		Börse Frankfurt in Grün: DAX beginnt Handel im Plus

19:12

TELL me! - der Schweizer Trading Podcast: Microsoft unter Kartellverdacht - Novartis auf einem guten Weg - bei Brenntag könnte das zyklische Tief 2025 kommen

17:58

Optimismus in Europa: Euro STOXX 50 zum Ende des Donnerstagshandels in der Gewinnzone

17:58

Freundlicher Handel in Frankfurt: LUS-DAX verbucht schlussendlich Gewinne

17:58

DAX aktuell: DAX zum Handelsende mit Zuschlägen

15:58

Börse Europa: STOXX 50-Börsianer greifen zu

12:26

Gewinne in Europa: STOXX 50 am Mittag mit Kursplus